Open2.166 | Close- |
Vol / Avg.1.166K / 8.996K | Mkt Cap77.806M |
Day Range2.166 - 2.166 | 52 Wk Range1.080 - 2.740 |
HCW Biologics Stock (NASDAQ: HCWB) stock price, news, charts, stock research, profile.
Open2.166 | Close- |
Vol / Avg.1.166K / 8.996K | Mkt Cap77.806M |
Day Range2.166 - 2.166 | 52 Wk Range1.080 - 2.740 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | -0.120 | 0.0300 | ||||
REV | 622.807K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Tony Butler | Assumes | Buy | Announces | - | 9.00 |
2023-04-19 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-30 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-23 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HCWB | HCW Biologics | 9.93% | 77.8M |
KZR | Kezar Life Sciences | 0.89% | 82.1M |
TTOO | T2 Biosystems | -4.51% | 69.9M |
ELTX | Elicio Therapeutics | 8.41% | 71.4M |
CLGN | CollPlant Biotechnologies | -1.69% | 66.5M |
You can purchase shares of HCW Biologics (NASDAQ: HCWB) through any online brokerage.
Other companies in HCW Biologics’s space includes: Kezar Life Sciences (NASDAQ:KZR), T2 Biosystems (NASDAQ:TTOO), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN) and Evelo Biosciences (NASDAQ:EVLO).
The latest price target for HCW Biologics (NASDAQ: HCWB) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 9.00 expecting HCWB to rise to within 12 months (a possible 315.57% upside). 5 analyst firms have reported ratings in the last year.
The stock price for HCW Biologics (NASDAQ: HCWB) is $2.1657 last updated Today at September 26, 2023 at 4:13 PM UTC.
There is no dividend information for HCW Biologics.
HCW Biologics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HCW Biologics Stock (NASDAQ: HCWB) stock price, news, charts, stock research, profile.
Open2.166 | Close- |
Vol / Avg.1.166K / 8.996K | Mkt Cap77.806M |
Day Range2.166 - 2.166 | 52 Wk Range1.080 - 2.740 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | -0.120 | 0.0300 | ||||
REV | 622.807K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Tony Butler | Assumes | Buy | Announces | - | 9.00 |
2023-04-19 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-30 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-23 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HCWB | HCW Biologics | 9.93% | 77.8M |
KZR | Kezar Life Sciences | 0.89% | 82.1M |
TTOO | T2 Biosystems | -4.51% | 69.9M |
ELTX | Elicio Therapeutics | 8.41% | 71.4M |
CLGN | CollPlant Biotechnologies | -1.69% | 66.5M |
You can purchase shares of HCW Biologics (NASDAQ: HCWB) through any online brokerage.
Other companies in HCW Biologics’s space includes: Kezar Life Sciences (NASDAQ:KZR), T2 Biosystems (NASDAQ:TTOO), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN) and Evelo Biosciences (NASDAQ:EVLO).
The latest price target for HCW Biologics (NASDAQ: HCWB) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 9.00 expecting HCWB to rise to within 12 months (a possible 315.57% upside). 5 analyst firms have reported ratings in the last year.
The stock price for HCW Biologics (NASDAQ: HCWB) is $2.1657 last updated Today at September 26, 2023 at 4:13 PM UTC.
There is no dividend information for HCW Biologics.
HCW Biologics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HCW Biologics Stock (NASDAQ: HCWB) stock price, news, charts, stock research, profile.
Open2.166 | Close- |
Vol / Avg.1.166K / 8.996K | Mkt Cap77.806M |
Day Range2.166 - 2.166 | 52 Wk Range1.080 - 2.740 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | -0.120 | 0.0300 | ||||
REV | 622.807K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Tony Butler | Assumes | Buy | Announces | - | 9.00 |
2023-04-19 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-30 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-23 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HCWB | HCW Biologics | 9.93% | 77.8M |
KZR | Kezar Life Sciences | 0.89% | 82.1M |
TTOO | T2 Biosystems | -4.51% | 69.9M |
ELTX | Elicio Therapeutics | 8.41% | 71.4M |
CLGN | CollPlant Biotechnologies | -1.69% | 66.5M |
You can purchase shares of HCW Biologics (NASDAQ: HCWB) through any online brokerage.
Other companies in HCW Biologics’s space includes: Kezar Life Sciences (NASDAQ:KZR), T2 Biosystems (NASDAQ:TTOO), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN) and Evelo Biosciences (NASDAQ:EVLO).
The latest price target for HCW Biologics (NASDAQ: HCWB) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 9.00 expecting HCWB to rise to within 12 months (a possible 315.57% upside). 5 analyst firms have reported ratings in the last year.
The stock price for HCW Biologics (NASDAQ: HCWB) is $2.1657 last updated Today at September 26, 2023 at 4:13 PM UTC.
There is no dividend information for HCW Biologics.
HCW Biologics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HCW Biologics Stock (NASDAQ: HCWB) stock price, news, charts, stock research, profile.
Open2.166 | Close- |
Vol / Avg.1.166K / 8.996K | Mkt Cap77.806M |
Day Range2.166 - 2.166 | 52 Wk Range1.080 - 2.740 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | -0.120 | 0.0300 | ||||
REV | 622.807K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Tony Butler | Assumes | Buy | Announces | - | 9.00 |
2023-04-19 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-30 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-23 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HCWB | HCW Biologics | 9.93% | 77.8M |
KZR | Kezar Life Sciences | 0.89% | 82.1M |
TTOO | T2 Biosystems | -4.51% | 69.9M |
ELTX | Elicio Therapeutics | 8.41% | 71.4M |
CLGN | CollPlant Biotechnologies | -1.69% | 66.5M |
You can purchase shares of HCW Biologics (NASDAQ: HCWB) through any online brokerage.
Other companies in HCW Biologics’s space includes: Kezar Life Sciences (NASDAQ:KZR), T2 Biosystems (NASDAQ:TTOO), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN) and Evelo Biosciences (NASDAQ:EVLO).
The latest price target for HCW Biologics (NASDAQ: HCWB) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 9.00 expecting HCWB to rise to within 12 months (a possible 315.57% upside). 5 analyst firms have reported ratings in the last year.
The stock price for HCW Biologics (NASDAQ: HCWB) is $2.1657 last updated Today at September 26, 2023 at 4:13 PM UTC.
There is no dividend information for HCW Biologics.
HCW Biologics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HCW Biologics Stock (NASDAQ: HCWB) stock price, news, charts, stock research, profile.
Open2.166 | Close- |
Vol / Avg.1.166K / 8.996K | Mkt Cap77.806M |
Day Range2.166 - 2.166 | 52 Wk Range1.080 - 2.740 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | -0.120 | 0.0300 | ||||
REV | 622.807K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Tony Butler | Assumes | Buy | Announces | - | 9.00 |
2023-04-19 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-30 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-23 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HCWB | HCW Biologics | 9.93% | 77.8M |
KZR | Kezar Life Sciences | 0.89% | 82.1M |
TTOO | T2 Biosystems | -4.51% | 69.9M |
ELTX | Elicio Therapeutics | 8.41% | 71.4M |
CLGN | CollPlant Biotechnologies | -1.69% | 66.5M |
You can purchase shares of HCW Biologics (NASDAQ: HCWB) through any online brokerage.
Other companies in HCW Biologics’s space includes: Kezar Life Sciences (NASDAQ:KZR), T2 Biosystems (NASDAQ:TTOO), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN) and Evelo Biosciences (NASDAQ:EVLO).
The latest price target for HCW Biologics (NASDAQ: HCWB) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 9.00 expecting HCWB to rise to within 12 months (a possible 315.57% upside). 5 analyst firms have reported ratings in the last year.
The stock price for HCW Biologics (NASDAQ: HCWB) is $2.1657 last updated Today at September 26, 2023 at 4:13 PM UTC.
There is no dividend information for HCW Biologics.
HCW Biologics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HCW Biologics Stock (NASDAQ: HCWB) stock price, news, charts, stock research, profile.
Open2.166 | Close- |
Vol / Avg.1.166K / 8.996K | Mkt Cap77.806M |
Day Range2.166 - 2.166 | 52 Wk Range1.080 - 2.740 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | -0.120 | 0.0300 | ||||
REV | 622.807K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Tony Butler | Assumes | Buy | Announces | - | 9.00 |
2023-04-19 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-30 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-23 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HCWB | HCW Biologics | 9.93% | 77.8M |
KZR | Kezar Life Sciences | 0.89% | 82.1M |
TTOO | T2 Biosystems | -4.51% | 69.9M |
ELTX | Elicio Therapeutics | 8.41% | 71.4M |
CLGN | CollPlant Biotechnologies | -1.69% | 66.5M |
You can purchase shares of HCW Biologics (NASDAQ: HCWB) through any online brokerage.
Other companies in HCW Biologics’s space includes: Kezar Life Sciences (NASDAQ:KZR), T2 Biosystems (NASDAQ:TTOO), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN) and Evelo Biosciences (NASDAQ:EVLO).
The latest price target for HCW Biologics (NASDAQ: HCWB) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 9.00 expecting HCWB to rise to within 12 months (a possible 315.57% upside). 5 analyst firms have reported ratings in the last year.
The stock price for HCW Biologics (NASDAQ: HCWB) is $2.1657 last updated Today at September 26, 2023 at 4:13 PM UTC.
There is no dividend information for HCW Biologics.
HCW Biologics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HCW Biologics Stock (NASDAQ: HCWB) stock price, news, charts, stock research, profile.
Open2.166 | Close- |
Vol / Avg.1.166K / 8.996K | Mkt Cap77.806M |
Day Range2.166 - 2.166 | 52 Wk Range1.080 - 2.740 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | -0.120 | 0.0300 | ||||
REV | 622.807K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Tony Butler | Assumes | Buy | Announces | - | 9.00 |
2023-04-19 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-30 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-23 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HCWB | HCW Biologics | 9.93% | 77.8M |
KZR | Kezar Life Sciences | 0.89% | 82.1M |
TTOO | T2 Biosystems | -4.51% | 69.9M |
ELTX | Elicio Therapeutics | 8.41% | 71.4M |
CLGN | CollPlant Biotechnologies | -1.69% | 66.5M |
You can purchase shares of HCW Biologics (NASDAQ: HCWB) through any online brokerage.
Other companies in HCW Biologics’s space includes: Kezar Life Sciences (NASDAQ:KZR), T2 Biosystems (NASDAQ:TTOO), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN) and Evelo Biosciences (NASDAQ:EVLO).
The latest price target for HCW Biologics (NASDAQ: HCWB) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 9.00 expecting HCWB to rise to within 12 months (a possible 315.57% upside). 5 analyst firms have reported ratings in the last year.
The stock price for HCW Biologics (NASDAQ: HCWB) is $2.1657 last updated Today at September 26, 2023 at 4:13 PM UTC.
There is no dividend information for HCW Biologics.
HCW Biologics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HCW Biologics Stock (NASDAQ: HCWB) stock price, news, charts, stock research, profile.
Open2.166 | Close- |
Vol / Avg.1.166K / 8.996K | Mkt Cap77.806M |
Day Range2.166 - 2.166 | 52 Wk Range1.080 - 2.740 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.150 | -0.120 | 0.0300 | ||||
REV | 622.807K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-01 | EF Hutton | Tony Butler | Assumes | Buy | Announces | - | 9.00 |
2023-04-19 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-30 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
2023-03-23 | EF Hutton | Constantine Davides | Reiterates | Buy | Maintains | - | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HCWB | HCW Biologics | 9.93% | 77.8M |
KZR | Kezar Life Sciences | 0.89% | 82.1M |
TTOO | T2 Biosystems | -4.51% | 69.9M |
ELTX | Elicio Therapeutics | 8.41% | 71.4M |
CLGN | CollPlant Biotechnologies | -1.69% | 66.5M |
You can purchase shares of HCW Biologics (NASDAQ: HCWB) through any online brokerage.
Other companies in HCW Biologics’s space includes: Kezar Life Sciences (NASDAQ:KZR), T2 Biosystems (NASDAQ:TTOO), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN) and Evelo Biosciences (NASDAQ:EVLO).
The latest price target for HCW Biologics (NASDAQ: HCWB) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 9.00 expecting HCWB to rise to within 12 months (a possible 315.57% upside). 5 analyst firms have reported ratings in the last year.
The stock price for HCW Biologics (NASDAQ: HCWB) is $2.1657 last updated Today at September 26, 2023 at 4:13 PM UTC.
There is no dividend information for HCW Biologics.
HCW Biologics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.